Gastroenteritis Clinical Trials

A listing of Gastroenteritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 53 clinical trials
A Study of E6011 in Participants With Active Crohn's Disease

The primary purpose of this study is to examine the efficacy and safety of E6011 at 12 weeks after administration by means of double-blind placebo-controlled trial.

small intestine
methotrexate
corticosteroids
sulfasalazine
ciprofloxacin
  • 21 views
  • 18 Sep, 2021
  • 125 locations
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

mirikizumab
  • 1735 views
  • 27 Sep, 2021
  • 881 locations
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC).

mirikizumab
  • 257 views
  • 26 Sep, 2021
  • 621 locations
Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease which often follows a relapsing/remitting course. Anti-TNF therapies are proven to be effective in UC and studies indicate that having adequate drug levels correlate with improved patient outcomes. It is unknown, however, if a high burden of disease at baseline impacts …

flexible sigmoidoscopy
corticosteroids
methotrexate
tumor necrosis factor
adalimumab
  • 0 views
  • 26 Sep, 2021
  • 1 location
A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

This study is designed to evaluate how the body processes and removes mirikizumab. The study will also evaluate safety and disease response in pediatric participants with UC taking mirikizumab. The study will last about 52 weeks and may include up to 17 visits.

immunomodulators
corticosteroids
janus kinase inhibitor
mirikizumab
  • 2 views
  • 26 Sep, 2021
  • 43 locations
A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease

This is a study in adults with Crohn's Disease who also have fistulas near the anus. The study has 2 parts. The first part is to find out more about what causes the fistulas. In this part of the study, tissue samples are taken from patients. The second part of …

fistulising crohn's disease
ustekinumab
methotrexate
corticosteroids
infliximab
  • 13 views
  • 26 Sep, 2021
  • 19 locations
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

ustekinumab
crohn's disease
  • 652 views
  • 26 Sep, 2021
  • 1005 locations
Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability

The objectives of the study are to evaluate the safety and tolerability of oral administration of MB-102, and to evaluate the use of MB-102 as a means of measuring gut permeability in normal participants (n=10) and in those with radiologic evidence of small bowel Crohn's disease (n=10).

crohn's disease
  • 9 views
  • 16 Sep, 2021
  • 1 location
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. This study will evaluate how well risankizumab works compared to ustekinumab. This study will assess change in Crohn's Disease Activity Index (CDAI). Risankizumab is an investigational drug being developed for the treatment of …

tumour necrosis
ustekinumab
risankizumab
tumor necrosis factor
abdominal pain
  • 106 views
  • 26 Sep, 2021
  • 484 locations
A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula

The main aim is to check the long term side effects of a repeat treatment of darvadstrocel and to see if that treatment improves symptoms of Crohn's disease and complex perianal fistula. Participants will attend 8 clinic visits and will receive 1 treatment of darvadstrocel at the third visit. A …

crohn's disease
remission
  • 0 views
  • 26 Sep, 2021
  • 30 locations